| Rank | Logo | Company | Market Cap | Country |
|---|---|---|---|---|
| 1 |  | Eli Lilly | $821.67 B | USA |
| 2 |  | Johnson & Johnson | $571.82 B | USA |
| 3 |  | AbbVie | $368.38 B | USA |
| 4 |  | Roche | $323.49 B | Switzerland |
| 5 |  | AstraZeneca | $292.10 B | UK |
| 6 |  | Novartis | $289.59 B | Switzerland |
| 7 |  | Merck | $283.08 B | USA |
| 8 |  | Amgen | $189.47 B | USA |
| 9 |  | Gilead Sciences | $175.40 B | USA |
| 10 |  | Novo Nordisk | $166.94 B | Denmark |
| 11 |  | Pfizer | $155.34 B | USA |
| 12 |  | Bristol-Myers Squibb | $120.90 B | USA |
| 13 |  | Vertex Pharmaceuticals | $114.71 B | USA |
| 14 |  | Sanofi | $105.56 B | France |
| 15 |  | GSK plc | $104.38 B | UK |
| 16 |  | CVS Health | $92.89 B | USA |
| 17 |  | Chugai Pharmaceutical | $89.17 B | Japan |
| 18 |  | Regeneron Pharmaceuticals | $78.66 B | USA |
| 19 |  | Takeda Pharmaceutical | $56.96 B | Japan |
| 20 |  | UCB | $54.83 B | Belgium |
| 21 |  | Jiangsu Hengrui Medicine | $54.10 B | China |
| 22 |  | Merck KGaA | $53.32 B | Germany |
| 23 |  | Zoetis | $51.71 B | USA |
| 24 |  | CSL | $45.96 B | Australia |
| 25 |  | Sun Pharmaceutical | $45.19 B | India |
| 26 |  | Bayer | $43.57 B | Germany |
| 27 |  | Galderma Group | $42.40 B | Switzerland |
| 28 |  | Argenx | $42.37 B | Netherlands |
| 29 |  | Lonza | $42.17 B | Switzerland |
| 30 |  | Alnylam Pharmaceuticals | $41.74 B | USA |
| 31 |  | WuXi AppTec | $41.61 B | China |
| 32 |  | Otsuka Holdings | $35.46 B | Japan |
| 33 |  | Teva Pharmaceutical Industries | $34.48 B | Israel |
| 34 |  | Daiichi Sankyō | $33.63 B | Japan |
| 35 |  | Sandoz Group | $33.40 B | Switzerland |
| 36 |  | BeOne Medicines | $32.42 B | USA |
| 37 |  | Insmed | $30.75 B | USA |
| 38 |  | Celltrion | $29.41 B | S. Korea |
| 39 |  | Biogen | $26.75 B | USA |
| 40 |  | Astellas Pharma | $26.73 B | Japan |
| 41 |  | Royalty Pharma | $26.48 B | UK |
| 42 |  | Hansoh Pharma | $24.80 B | China |
| 43 |  | United Therapeutics | $23.24 B | USA |
| 44 |  | BioNTech | $22.61 B | Germany |
| 45 |  | LabCorp | $22.03 B | USA |
| 46 |  | Moderna | $20.69 B | USA |
| 47 |  | Roivant Sciences | $19.89 B | UK |
| 48 |  | Revolution Medicines | $19.44 B | USA |
| 49 |  | Incyte | $18.35 B | USA |
| 50 |  | WuXi Biologics | $18.18 B | China |
| 51 |  | Innovent Biologics | $17.96 B | China |
| 52 |  | Shionogi | $17.94 B | Japan |
| 53 |  | West Pharmaceutical Services | $17.22 B | USA |
| 54 |  | Divis Laboratories | $17.04 B | India |
| 55 |  | Sichuan Biokin Pharmaceutical | $16.18 B | China |
| 56 |  | Genmab | $15.89 B | Denmark |
| 57 |  | Viatris | $15.82 B | USA |
| 58 |  | Torrent Pharmaceuticals | $15.30 B | India |
| 59 |  | Ipsen | $14.46 B | France |
| 60 |  | Ascendis Pharma | $13.96 B | Denmark |
| 61 |  | Sino Biopharmaceutical | $13.83 B | China |
| 62 |  | Akeso | $13.78 B | China |
| 63 |  | BridgeBio Pharma | $13.59 B | USA |
| 64 |  | Swedish Orphan Biovitrum | $13.51 B | Sweden |
| 65 |  | CSPC Pharmaceutical Group Limited | $13.14 B | China |
| 66 |  | Neurocrine Biosciences | $13.11 B | USA |
| 67 |  | Regencell Bioscience | $13.04 B | Hong Kong |
| 68 |  | Medpace | $12.90 B | USA |
| 69 |  | Alteogen | $12.81 B | S. Korea |
| 70 |  | Elanco | $12.34 B | USA |
| 71 |  | Summit Therapeutics | $12.09 B | UK |
| 72 |  | Ionis Pharmaceuticals | $11.83 B | USA |
| 73 |  | Dr. Reddy's Laboratories | $11.53 B | India |
| 74 |  | Orion Corporation | $11.35 B | Finland |
| 75 |  | Avidity Biosciences | $11.24 B | USA |
| 76 |  | Jazz Pharmaceuticals | $11.10 B | Ireland |
| 77 |  | Exelixis | $11.06 B | USA |
| 78 |  | Lupin Limited | $11.04 B | India |
| 79 |  | Financière de Tubize | $10.91 B | Belgium |
| 80 |  | Cipla | $10.73 B | India |
| 81 |  | BioMarin Pharmaceutical | $10.66 B | USA |
| 82 |  | Recordati | $10.29 B | Italy |
| 83 |  | Madrigal Pharmaceuticals | $10.13 B | USA |
| 84 |  | Fosun Pharma | $9.81 B | China |
| 85 |  | Abivax | $9.80 B | France |
| 86 |  | Zydus Lifesciences | $9.50 B | India |
| 87 |  | Shenzhen Salubris Pharmaceuticals | $9.34 B | China |
| 88 |  | Huadong Medicine (HD Medicine) | $9.09 B | China |
| 89 |  | ImmunityBio | $8.80 B | USA |
| 90 |  | Baxter | $8.79 B | USA |
| 91 |  | Mankind Pharma | $8.70 B | India |
| 92 |  | Haisco Pharmaceutical Group | $8.41 B | China |
| 93 |  | Eisai | $8.41 B | Japan |
| 94 |  | Sinopharm | $8.29 B | China |
| 95 |  | Axsome Therapeutics | $8.07 B | USA |
| 96 |  | Praxis Precision Medicines | $8.04 B | USA |
| 97 |  | Bio-Techne | $7.94 B | USA |
| 98 |  | Arrowhead Pharmaceuticals | $7.94 B | USA |
| 99 |  | Vaxcyte | $7.88 B | USA |
| 100 |  | Aurobindo Pharma | $7.74 B | India |
Largest pharma companies by market cap
